Lana Medical Company Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6.35	18.75	3.3	3.52
Cash & Short-Term Investments	6.35	18.75	3.3	3.52
Cash Growth	-66.14%	467.79%	-6.03%	-
Accounts Receivable	37.22	18.91	32.77	31.21
Other Receivables	1.62	1.42	-	0.9
Receivables	38.84	20.33	32.77	32.11
Inventory	4.7	2.97	4.09	4.07
Prepaid Expenses	1.6	0.54	0.17	0.06
Other Current Assets	6.14	7.25	4.5	2.7
Total Current Assets	57.63	49.84	44.83	42.46
Property, Plant & Equipment	36.26	26.03	18.39	14.81
Long-Term Investments	8.71	-	-	-
Other Intangible Assets	0.17	0.2	-	-
Total Assets	102.77	76.07	63.22	57.28
Accounts Payable	5.8	1.69	1.14	1.17
Accrued Expenses	9.73	5.6	3.62	2.52
Short-Term Debt	-	-	2.04	-
Current Portion of Long-Term Debt	6.28	1.86	1.58	1.8
Current Portion of Leases	1.02	0.47	0.31	0.31
Current Income Taxes Payable	1.33	1.52	1.13	1.2
Current Unearned Revenue	2.01	3.36	-	0.54
Other Current Liabilities	4.65	1.92	0.98	0.35
Total Current Liabilities	30.83	16.43	10.79	7.88
Long-Term Debt	2.37	3.65	2.73	5.43
Long-Term Leases	5.74	5.34	0.88	1.21
Total Liabilities	41.77	27.31	15.79	15.7
Common Stock	36	36	30	30
Additional Paid-In Capital	11.52	11.52	-	-
Retained Earnings	13.73	1.25	16.96	11.47
Comprehensive Income & Other	-0.24	-	0.47	0.11
Shareholders' Equity	61	48.76	47.42	41.57
Total Liabilities & Equity	102.77	76.07	63.22	57.28
Total Debt	15.4	11.32	7.53	8.74
Net Cash (Debt)	-9.05	7.43	-4.23	-5.23
Net Cash Per Share	-1.68	1.63	-0.94	-1.59
Filing Date Shares Outstanding	5.4	5.4	5.4	3.28
Total Common Shares Outstanding	5.4	5.4	4.5	3.28
Working Capital	26.8	33.41	34.04	34.58
Book Value Per Share	11.30	9.03	10.54	12.67
Tangible Book Value	60.83	48.56	47.42	41.57
Tangible Book Value Per Share	11.26	8.99	10.54	12.67
Buildings	10.59	1.95	1.95	1.95
Machinery	25.45	10.91	8.2	6.97
Construction In Progress	-	12.38	11.22	7.36
Leasehold Improvements	2	0.86	0.25	0.25

Source: S&P Global Market Intelligence. Standard template. Financial Sources.